Adjuvant Capital is the famous VC, which was founded in 2012. The leading representative office of defined VC is situated in the New York. The fund was located in North America if to be more exact in United States.
The important activity for fund was in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in 2-6 deals every year. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations.
The current fund was established by Charlie Petty, Glenn Rockman, Kabeer Aziz.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight X-Vax Technology, Themis Bioscience, InDevR. Among the most popular fund investment industries, there are Biotechnology, Health Care. The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Adjuvant Capital, startups are often financed by aws Gru00fcnderfonds (aws Founders Fund), Wellington Partners, Ventech. The meaningful sponsors for the fund in investment in the same round are aws Gru00fcnderfonds (aws Founders Fund), Wellington Partners, Ventech.
Related Funds
Funds with similar focus
| Fund Name | Location |
| efinanceworks | New York, New York, United States |
| Encavis | Germany, Hamburg |
| Food & Fun Ventures | Florida, Palm Beach, United States |
| GMT Capital | Atlanta, Georgia, United States |
| Granite Hacarmel | HaMerkaz, Israel, Netanya |
| Harbor Pacific Capital | China, Hong Kong, Hong Kong Island |
| Hyperion Israel Venture Partners | - |
| Jia Zhong Guang Li Touzi | Beijing, Beijing, China |
| Jinshan Capital | Changsha, China, Jiangsu |
| Latitude Consultants Limited | - |
| Responder Ventures | Florida, United States, West Palm Beach |
| Scale Capital | Chile, Region Metropolitana, Santiago |
| Seven Peaks Software | Bangkok, Krung Thep, Thailand |
| Space3ac | Gdansk, Poland, Pomorskie |
| Startup Labs | California, San Francisco, United States |
| Tensility Venture Partners | Chicago, Illinois, United States |
| Tuode Capital | - |
| WERCBench Labs | Milwaukee, United States, Wisconsin |
| Yingzhi (Yinchuan) Touzi Guanli Co., Ltd. | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Memo Therapeutics | $27M | 02 Nov 2023 | Zurich, Zurich, Switzerland | ||
Codagenix | $25M | 15 Feb 2023 | New York, United States | ||
InDevR | $9M | 17 Jan 2023 | Boulder, Colorado, United States | ||
Minervax | $25M | 15 Dec 2022 | Denmark, Capital Region of Denmark, Denmark | ||
Curevo | $26M | 16 Nov 2022 | - | ||
Memo Therapeutics | $25M | 16 Feb 2022 | Zurich, Zurich, Switzerland | ||
Curevo | $60M | 07 Jan 2022 | - | ||
54gene | $25M | 16 Sep 2021 | Washington, District of Columbia, United States | ||
VitriVax | 07 Jul 2021 | Boulder, Colorado, United States |
– African genomics startup 54gene has raised $25m in Series B funding.
– Pan-African venture capital firm Cathay AfricInvest Innovation Fund led this round.
– Lead investor from the company’s Series A funding, Adjuvant Capital, invested once again with participation from other VCs including KdT Ventures, Plexo Capital, Endeavor Catalyst and Ingressive Capital.
– The company has raised a total of $45m since its inception.
– YishengBio announced that it has raised US$130m in Series B funding.
– The round was co-led by Oceanpine and OrbiMed.
– The company’s institutional investors include: OrbiMed, Oceanpine, EightRoad, F-Prime Capital, 3W Capital, Hillhouse Capital, Adjuvant Capital, MSA Capital, AIHC, Epiphron Capital, Superstring Capital, Haitong International, etc.
– The company is engaged in discovering, developing and commercializing innovative biotherapeutics for cancers and infectious diseases using novel PIKA® immunomodulating technology.
– The company operates in China, USA, and Singapore with over 500 employees.
– YSJA™ rabies vaccine is the first alum-free lyophilized rabies vaccine launched in China.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Memo Therapeutics | $27M | 02 Nov 2023 | Zurich, Zurich, Switzerland | ||
Codagenix | $25M | 15 Feb 2023 | New York, United States | ||
InDevR | $9M | 17 Jan 2023 | Boulder, Colorado, United States | ||
Minervax | $25M | 15 Dec 2022 | Denmark, Capital Region of Denmark, Denmark | ||
Curevo | $26M | 16 Nov 2022 | - | ||
Memo Therapeutics | $25M | 16 Feb 2022 | Zurich, Zurich, Switzerland | ||
Curevo | $60M | 07 Jan 2022 | - | ||
54gene | $25M | 16 Sep 2021 | Washington, District of Columbia, United States | ||
VitriVax | 07 Jul 2021 | Boulder, Colorado, United States |
